Loading clinical trials...
Loading clinical trials...
The study is designed to evaluate the value of ctDNA in predicting the drug efficacy of chemotherapy for metastatic colorectal cancer.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fudan University
NCT06434896 · Circulating Tumor DNA, Recurrence, and more
NCT07310537 · Colorectal Cancer (Diagnosis), Colorectal Liver Metastasis (CRLM), and more
NCT04530890 · Breast Cancer, Digestive Cancer, and more
NCT04966663 · Non Small Cell Lung Cancer, Complete Surgical Resection, and more
NCT04434040 · Breast Cancer, Triple Negative Breast Cancer, and more
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions